Moreover, synthetic miR-29b mimicspotentiated the growth-inhibitory effects of the DNMT-inhibitor 5-azacitidine [47], suggesting new strategies based upon DNA-demethylating agents/miRNAscombination in the treatment of MM. Here, DNMT1 is linked to Miyoshi myopathy.